Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Active Pharmaceutical Ingredients Market to Exceed $339 Billion by 2030; Innovative APIs, Lonza Group AG Lead
EIN Presswire
The Business Research Company's Active Pharmaceutical Ingredients Market to Exceed $339 Billion by 2030; Innovative APIs, Lonza Group AG Lead LONDON, GREATER LONDON, UNITED KINGDOM, October 9, 2026 /EINPresswire.com/ -- "The active...
‘Putting the mouth back into the body’: physicians urged to make oral health part of routine care
Royal College of Physicians
The latest issue of the RCP’s Future Healthcare Journal (FHJ) calls for oral health to be more closely integrated into medicine, highlighting its importance to prevention, diagnosis and the management of wider health conditions.
Retension Pharmaceuticals Announces Pricing of Initial Public Offering
GlobeNewswire, Inc.
FALLS CHURCH, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (Nasdaq: RTSN) (“Retension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and...
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire, Inc.
NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of its...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
GlobeNewswire, Inc.
NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the...
New York State Announces Recognition of the Office of Mental Health’s Chief Advocacy Officer
New York State Office of Mental Health
Chief Advocacy Officer Liz Breier, center, celebrates with OMH colleagues after being honored by the Alliance for Rights and Recovery.
Three Concurrent Exhibitions to Feature Ten Themed Business Matching Sessions Precisely Connecting Businesses with Portuguese- and Spanish-Speaking Markets and Technology and Innovation Co-operation
Macao Government News
MACAU, October 9 - Building on Macao’s unique advantages as a platform between China and Portuguese- and Spanish-speaking countries and as a regional economic and trade hub, the Commerce and Investment Promotion Institute (IPIM) will concurrently...
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
GlobeNewswire, Inc.
WILMINGTON, Del., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that the Centers for Medicare & Medicaid Services (“CMS”) has awarded its PPO...
Attorney General James Secures Over $1 Million from Ascend Laboratories and Mayne Pharma for Illegal Scheme to Inflate Drug Prices
New York Attorney General
NEW YORK – New York Attorney General Letitia James today joined a bipartisan coalition of 47 other attorneys general in securing $1 million from Ascend Laboratories (Ascend) and Mayne Pharma (Mayne) for their role in a long-running, coordinated...
Hope & Help Breaks Ground on New Orlando Center Bringing Medical Care, Mental Health, and Support Services Together
EIN Presswire
Expected to open in 2027, the Orange Blossom Trail location will offer a convenient, one-stop destination for whole-person care.
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS
GlobeNewswire, Inc.
NEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims &...
Clever Care Health Plan Achieves 4.5-Star Medicare Advantage Rating from CMS for Star Year 2027
GlobeNewswire, Inc.
HUNTINGTON BEACH, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clever Care Health Plan, a culturally competent and attuned Medicare Advantage plan, today announced that its Medicare Advantage plans have been awarded a 4.5-star rating from the Centers...
Utah Receives Top Honors in Government Information Technology
Utah Division of Technology Services
Utah’s state government is once again being recognized for outstanding efforts in information technology.
Without Missing a Beat: Mike O’Callaghan Military Medical Center Advances Cardiac Care
DVIDS - Georgia
NELLIS AIR FORCE BASE, Nev. – The Mike O’Callaghan Military Medical Center cardiology team is writing the playbook for advanced heart care through innovation, collaboration, and a commitment to patient-centered care.
Rua Bioscience and PharmAla Biotech partner to supply medicinal MDMA in New Zealand
GlobeNewswire, Inc.
TAIRĀWHITI, New Zealand and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Rua Bioscience Limited (NZX: RUA) (“Rua”) and PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) (“PharmAla”) announce that Rua and PharmAla Biotech Inc., a subsidiary...
Haptic Patch Reduced Pain and Improved Range of Motion in Randomized Controlled Trial Presented at Business of Pain 2026
EIN Presswire
Randomized study of 118 adults: drug-free FREEDOM haptic patch significantly reduced pain and improved range of motion vs. placebo in 14 days.
XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
GlobeNewswire, Inc.
● Clinical Trial Application planned for filing with Health Canada, extending the Company’s international regulatory strategy for gout program XRx-026 ● CALGARY, Alberta, Oct. 08, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the...
Lanclos 1063, LLC Announces Investment in Groundbreaking AI Medical Imaging
EIN Presswire
COVINGTON, LA, UNITED STATES, October 8, 2026 /EINPresswire.com/ -- Lanclos 1063, a Louisiana-based private investment house, announces an investment and partnership with AI:ON Innovations (aion.health), an AI-powered medical imaging...
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
GlobeNewswire, Inc.
New NIH Award will Initially Provide NeuroOne Approximately $200,000 through April 2027 EDEN PRAIRIE, Minn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical...
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
GlobeNewswire, Inc.
ROCKVILLE, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (NASDAQ: NBP) today announced that updated results from the Phase 1b combination study of givastomig, a Claudin 18.2 (CLDN18.2) x 4-1BB bispecific antibody, in combination...
Sign up for:
Health Industry Watch
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.